XLON
NANO
Market cap6mUSD
Jul 09, Last price
2.50GBP
1D
-9.75%
1Q
-47.81%
Jan 2017
-94.44%
IPO
-95.08%
Name
Nanoco Group PLC
Chart & Performance
Notes
No notes on this company yet
Write a private note on this company, for your eyes only
Profile
Nanoco Group plc, along with its subsidiaries, specializes in the innovation, production, and commercialization of advanced nanoscale materials tailored for a diverse range of commercial sectors. Its product portfolio features CFQD quantum dots, which are fluorescent semiconductor nanoparticles utilized for applications such as OLED and µLED color conversion, quantum dot electroluminescence (QD-EL), and security tagging. Further offerings include HEATWAVE quantum dots, designed for the sensor industry, and VIVODOTS nanoparticles, specifically engineered for medical and veterinary applications. The company maintains a significant international footprint, with operations extending across the United Kingdom, Japan, Singapore, Holland, France, Taiwan, Canada, Saudi Arabia, and the United States. Established in 2001, Nanoco Group plc is headquartered in Runcorn, UK, having previously traded as Evolutec Group plc before rebranding to its current name in April 2009.
IPO date
May 01, 2009
Employees
36
Domiciled in
GB
Incorporated in
GB
Valuation
Title GBP in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|---|---|---|---|
| 2025‑07 | 2024‑07 | 2023‑07 | 2022‑07 | 2021‑07 | 2020‑07 | 2019‑07 | 2018‑07 | 2017‑07 | 2016‑07 | |
| Income | ||||||||||
Revenues | ||||||||||
Cost of revenue | ||||||||||
Unusual Expense (Income) | ||||||||||
NOPBT | ||||||||||
NOPBT Margin | ||||||||||
Operating Taxes | ||||||||||
Tax Rate | ||||||||||
NOPAT | ||||||||||
Net income | ||||||||||
Dividends | ||||||||||
Dividend yield | ||||||||||
Proceeds from repurchase of equity | ||||||||||
BB yield | ||||||||||
| Debt | ||||||||||
Debt current | ||||||||||
Long-term debt | ||||||||||
Deferred revenue | ||||||||||
Other long-term liabilities | ||||||||||
Net debt | ||||||||||
| Cash flow | ||||||||||
Cash from operating activities | ||||||||||
CAPEX | ||||||||||
Cash from investing activities | ||||||||||
Cash from financing activities | ||||||||||
FCF | ||||||||||
| Balance | ||||||||||
Cash | ||||||||||
Long term investments | ||||||||||
Excess cash | ||||||||||
Stockholders' equity | ||||||||||
Invested Capital | ||||||||||
ROIC | ||||||||||
ROCE | ||||||||||
| EV | ||||||||||
Common stock shares outstanding | ||||||||||
Price | ||||||||||
Market cap | ||||||||||
EV | ||||||||||
EBITDA | ||||||||||
EV/EBITDA | ||||||||||
Interest | ||||||||||
Interest/NOPBT | ||||||||||